Identity, Purity, Quantity, Sterility, and Endotoxin Explained

Five terms, five different questions

Quality discussions become unreliable when distinct attributes are collapsed into one word. Identity, purity, quantity, sterility, and endotoxin each ask a different question and require fit-for-purpose evidence.

A result for one attribute does not automatically answer another. The clearest review states the claim, method, sample, result, and limitation for each attribute separately.

Identity: is the represented molecule present?

Identity testing supports whether a sample contains the expected molecule. For peptides, mass spectrometry may contribute identity evidence by comparing observed ions with the expected molecular mass; other procedures may be appropriate depending on the material.

A dominant HPLC peak does not identify itself. The peak must be connected to suitable identity evidence.

Purity: what other components are detected?

Purity procedures examine impurities or the relative composition visible under defined analytical conditions. HPLC area percentage is common, but it describes integrated detector response—not necessarily the target peptide’s share of total vial mass.

Interpret the result with its method, detection conditions, integration, sample preparation, and reporting threshold.

Quantity or assay: how much target material is present?

Quantity addresses the amount of analyte or material, often against a calibrated reference or validated quantitative procedure. A nominal label claim and an HPLC purity percentage do not establish quantity by themselves.

Clarify whether a report measures target-peptide content, total filled mass, net weight, or another quantity; those values are not interchangeable.

Sterility: are viable microorganisms absent under the test?

Sterility is a microbiological attribute evaluated with specified procedures and sampling. Chemical identity and purity tests cannot establish sterility. A clean-looking vial, filtration statement, or generic facility claim is not a sterility-test result.

Sterility testing also does not retrospectively prove that every unit remained uncontaminated throughout handling and storage; manufacturing controls and container integrity matter alongside testing.

Endotoxin: a separate pyrogen-related concern

Bacterial endotoxins are components associated with gram-negative bacteria. Endotoxin testing is distinct from sterility testing: a sample may lack viable organisms yet still contain endotoxin, and a sterility result does not answer the endotoxin question.

FDA guidance emphasizes suitable methods, product-specific verification, interference controls, and appropriate limits. A bare ‘endotoxin tested’ statement is incomplete without the method, result, units, specification, and sample connection.

Build an attribute-by-attribute evidence matrix

For each quality claim, record whether it was tested, the method, the result, the acceptance limit, the laboratory, and the matching lot. Mark missing evidence as not reported rather than assuming pass or fail.

The resulting matrix is more honest and useful than a single overall quality score built from one purity number.

• Identity: expected versus observed result
• Purity: method-specific impurity or area result
• Quantity: calibrated assay or clearly defined mass measurement
• Sterility: microbiological method, sample plan, and result
• Endotoxin: validated method, units, limit, and result

The evidence must fit the intended claim

Analytical procedure validation is purpose-dependent. Specificity, accuracy, precision, range, detection capability, and robustness are considered according to what the method is intended to establish.

A responsible review therefore avoids asking whether a product was simply ‘lab tested.’ It asks which attributes were tested, how, on which sample, and with what outcome.